Antiangiogenic activity of the endocannabinoid anandamide: Correlation to its tumor-suppressor efficacy

Journal of Cellular Physiology

Volumn 211, Issue 2, 2007, Pages 495-503

  Pisanti, Simona ^a   Borselli, Cristina ^b   Oliviero, Olimpia ^b   Laezza, Chiara ^c   Gazzerro, Patrizia ^a   Bifulco, Maurizio ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; BASIC FIBROBLAST GROWTH FACTOR; ENDOCANNABINOID; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL PROLIFERATION; CELL STIMULATION; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; MICROENVIRONMENT; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THYROID TUMOR; TUMOR CELL CULTURE; TUMOR VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARACHIDONIC ACIDS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCANNABINOIDS; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; POLYUNSATURATED ALKAMIDES; RATS; RECEPTOR, CANNABINOID, CB1; SPHEROIDS, CELLULAR; SWINE; THYROID NEOPLASMS;

EID: 34147215056     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20954     Document Type: Article

References (46)

1. Baeuerle PA, Henkel T. 1994. Function and activation of NFkB in the immune system. Annu Rev Immunol 12:141.
2. Barkett M, Gilmore TD. 1999. Control of apoptosis by Rel/NfkB transcription factors. Oncogene 18:6910.
3. Beckner ME. 1999. Factors promoting tumor angiogenesis. Cancer Invest 17:594-623.
4. Beg AA, Baltimore D. 1996. An essential role for NFkB in preventing TNF-α induced cell death. Science 274:782.
5. Bifulco M, Di Marzo V. 2002. The endocannabinoid system as a target for the development of new drugs for cancer therapy. Nat Med 8:547-550.
6. Bifulco M, Laezza C, Portella G, Vitale M, Orlando P, De Petrocellis L, Di Marzo V. 2001. Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth, FASEB J 15:2745-2747.
7. Bifulco M, Laezza C, Pisanti S, Gazzerro P. 2006. Cannabinoids and cancer: Pros and cons of an antitumour strategy. Br J Pharmacol 148:123-135.
8. Blazquez C, Casanova ML, Planas A, Del Pulgar TG, Villanueva C, Fernandez-Acenero MJ, Aragones J, Huffman JW, Jorcano JL, Guzman M. 2003. Inhibition of tumor angiogenesis by cannabinoids. FASEB J 17:529-531.
9. Borselli C, Oliviero O, Battista S, Ambrosio L, Netti PN. 2006. Induction of directional sprouting angiogenesis by matrix gradients. J Biomed Mater Res A (In press).
10. Bussolino F, Mantovani A, Persico G. 1997. Molecular mechanisms of blood vessel formation. Trends Biochem Sci 22:251-256.
11. Carmeliet P. 2003. Angiogenesis in health and disease. Nature Med 9:653-660.
12. Casanova ML, Blazquez C, Martinez-Palacio J, Villanueva C, Fernandez-Acenero MJ, Huffman JW, Jorcano JL, Guzman M. 2003. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 111:43-50.
13. David L, Dulong V, Le Cerf D, Chauzy C, Norris V, Delpech B, Lamacz M, Vannier JP. 2004. Reticulated hyaluronan hydrogels: A model for examining cancer cell invasion in 3D. Matrix Biol 23:183-193.
14. Davis GE, Senger DR. 2005. Endothelial extracellular matrix: Biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 97:1093-1107.
15. Davis GE, Bayless KJ, Mavila A. 2002. Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices. Anat Rec 268:252-275.
16. De Martin R, Hoeth M, Hofer-Warbinek R, Schmid JA. 2000. The transcription factor NF-kappa B and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol 20:E83-E88.
17. De Petrocellis L, Cascio MG, Di Marzo V. 2004. The endocannabinoid system: A general view and latest additions. Br J Pharmacol 141:765-774.
18. Derkinderen P, Ledent C, Parmentier M, Girault JA. 2001. Cannabinoids activate p38 mitogen-activated protein kinase through CB1 receptors in hippocampus. J Neurochem 77:957.
19. Do Y, McKallip RJ, Nagarkatti M, Nagarkatti PS. 2004. Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NFkB-dependent apoptosis: Novel role for endogenous and exogenous cannabinoids in immunoregulation. J Immunol 173:2373-2382.
20. Erlandsson N, Baumann OG, Rossler K, Kaufmann KM, Giehl T, Wirth T, Thiel G. 2002. Lack of correlation between NFkB activation and induction of programmed cell death in PC12 pheocromocytoma cells trated with 6-htdroxidopamine or the cannabinoid receptor 1-agonist CP55,940. Biochem Pharmacol 64:487.
21. Ferrara N, Kerbel RS. 2005. Angiogenesis as a therapeutic target. Nature 438:967-974.
22. Folkman J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31.
23. Grimaldi C, Pisanti S, Laezza C, Malfitano AM, Santoro A, Vitale M, Caruso MG, Notarnicola M, Iacuzzo I, Portella G, Di Marzo V, Bifulco M. 2006. Anandamide inhibits adhesion and migration of breast cancer cells. Exp Cell Res 312:363-373.
24. Guzman M. 2003. Cannabinoids: Potential anticancer agents. Nat Rev Cancer 3:745-755.
25. Hisano N, Yatomi Y, Satoh K, Akimoto S, Mitsumata M, Fujino MA, Ozaki Y. 1999. Induction and suppression of endothelial cell apoptosis by sphingolipids: A possible in vitro model for cell-cell interactions between platelets and endothelial cells. Blood 93:4293-4299.
26. Ingber DE. 2002. Mechanical signalling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ Res 91:877-887.
27. 9- tetrahydrocannabinol is mediated through the inhibition of NFkB/ Rel activation. Mol Pharmacol 50:334.
28. Korff T, Augustin HG. 1998. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol 143:1341-1352.
29. Laezza C, Pisanti S, Crescenzi E, Bifulco M. 2006. Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells. FEBS Lett 580:6076-6082.
30. Lafleur MA, Hollenberg MD, Atkinson SJ, Knauper V, Murphy G, Edwards DR. 2001. Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species. Biochem J 357:107-115.
31. Liu J, Gao B, Mirshahi F, Sanyal AJ, Khanolkar AD, Makriyannis A, Kunos G. 2000. Functional CBI cannabinoid receptors in human vascular endothelial cells. Biochem J 346:835-840.
32. Malfitano AM, Matarese G, Pisanti S, Grimaldi C, Laezza C, Bisogno T, Di Marzo V, Lechler RI, Bifulco M. 2006. Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis. J Neuroimmunol 171:110-119.
33. Melck D, De Petrocellis L, Orlando P, Bisogno T, Laezza C, Bifulco M, Di Marzo V. 2000. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology 141:118-126.
34. Pepper MS. 2001. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21:1104-1117.
35. Portella G, Laezza C, Laccetti P, De Petrocellis L, Di Marzo V, Bifulco M. 2003. Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading. Actions on signals involved in angiogenesis and metastasis. FASEB J 17:1771-1773.
36. Risau W. 1997. Mechanisms of angiogenesis. Nature 386:671-674.
37. Romano MF, Lamberti A, Tassone P, Alfinito F, Costantini S, Chiurazzi F, Defrance T, Monelli P, Tuccillo F, Turco MC, Venuta S. 1998. Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leucemia cells. Blood 92:990-995.
38. Rueda D, Galve-Roperh I, Haro A, Guzman M. 2000. The CB1 cannabinoid receptor is couplet to the activation of c-Jun N-terminal kinase. Mol Pharmacol 58:814-820.
39. Siegmund SV, Uchinami H, Osawa Y, Brenner DA, Schwabe RF. 2005. Anandamide induces necrosis in primary hepatic stellate cells. Hepatology 41:1085-1095.
40. Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA. 1995. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J 14:2876-2883.
41. Wagner J A, Varga K, Jarai Z, Kunos G. 1999. Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension 33:429-434.
42. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
43. Xin X, Borzacchiello A, Netti PA, Ambrosio L, Nicolais L. 2004. Hyaluronic-acid-based semi-interpenetrating materials. J Biomater Sci Polym Ed 15:1223-1236.
44. Yamaji K, Sarker KP, Kawahara K, Iino S, Yamakuchi M, Abeyama K, Hashiguchi T, Maruyama I. 2003. Anandamide induces apoptosis in human endothelial cells: Its regulation system and clinical implications. Thromb Haemost 89:875-884.
45. Yang B, Cao DJ, Sainz I, Colman RW, Guo Y. 2004. Different roles of ERK and p38 MAP kinases during tube formation from endothelial cells cultured in 3-dimensional collagen matrices. J Cell Physiol 200:360-369.
46. Yue TL, Ni J, Romanic AM, Gu JL, Keller P, Wang C, Kumar S, Yu GL, Hart TK, Wang X, Xia Z, DeWolf WE Jr, Feuerstein GZ. 1999. TL1 a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells. Involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase) and caspase-3-like protease. J Biol Chem 274:1479-1486.